S. Boos

Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer

R. Rad, P. Jung, H. Hermeking, 2021, Cellular and molecular gastroenterology and hepatology.

Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy

R. Offringa, Michael Volkmar, Susann Wendler, 2020, Nature Communications.

Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer

B. Kuster, P. Jung, H. Hermeking, 2020, Cell Communication and Signaling.

Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells

P. Jung, H. Hermeking, Markus Kaller, 2018, Nature Communications.

Oncogenic KRas-induced Increase in Fluid-phase Endocytosis is Dependent on N-WASP and is Required for the Formation of Pancreatic Preneoplastic Lesions

R. Schmid, I. Heid, J. Siveke, 2016, EBioMedicine.

Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis1

R. Rad, P. Jung, A. Menssen, 2019, Neoplasia.

Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer

B. Kuster, P. Jung, H. Hermeking, 2020, Cell Communication and Signaling.